

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 7.42268877 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 7.42268877 |
| 3 | fatty acid elongation (GO:0030497) | 4.96374087 |
| 4 | myelin maintenance (GO:0043217) | 4.58105785 |
| 5 | axon ensheathment (GO:0008366) | 4.54317447 |
| 6 | ensheathment of neurons (GO:0007272) | 4.54317447 |
| 7 | leukocyte aggregation (GO:0070486) | 4.52974350 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.45940809 |
| 9 | myelination (GO:0042552) | 4.44605204 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.39237049 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.39237049 |
| 12 | amyloid precursor protein metabolic process (GO:0042982) | 4.18070645 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.07811469 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93915948 |
| 15 | T cell migration (GO:0072678) | 3.92492132 |
| 16 | creatine metabolic process (GO:0006600) | 3.84427976 |
| 17 | negative T cell selection (GO:0043383) | 3.79775931 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75757658 |
| 19 | mast cell activation (GO:0045576) | 3.73232808 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72334197 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.66165528 |
| 22 | amyloid precursor protein catabolic process (GO:0042987) | 3.64850240 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64794131 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.64692589 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56950360 |
| 26 | cholesterol biosynthetic process (GO:0006695) | 3.40295679 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32486399 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.32486399 |
| 29 | interferon-gamma production (GO:0032609) | 3.30768614 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21181464 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.21181464 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21181464 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.21181464 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21181464 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21181464 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.20737522 |
| 37 | response to type I interferon (GO:0034340) | 3.19801145 |
| 38 | T cell receptor signaling pathway (GO:0050852) | 3.18735978 |
| 39 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.17190175 |
| 40 | cellular response to type I interferon (GO:0071357) | 3.17159903 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.17159903 |
| 42 | response to lipoprotein particle (GO:0055094) | 3.13693796 |
| 43 | hemidesmosome assembly (GO:0031581) | 3.13212624 |
| 44 | membrane raft organization (GO:0031579) | 3.12726862 |
| 45 | positive regulation of interleukin-2 production (GO:0032743) | 3.11171133 |
| 46 | mast cell activation involved in immune response (GO:0002279) | 3.09017240 |
| 47 | mast cell degranulation (GO:0043303) | 3.09017240 |
| 48 | sterol biosynthetic process (GO:0016126) | 3.07174996 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.06383555 |
| 50 | detection of other organism (GO:0098543) | 3.05277916 |
| 51 | thymic T cell selection (GO:0045061) | 3.04864888 |
| 52 | detection of bacterium (GO:0016045) | 3.03221819 |
| 53 | activated T cell proliferation (GO:0050798) | 3.01947472 |
| 54 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.96729255 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.95649362 |
| 56 | response to interleukin-15 (GO:0070672) | 2.95523096 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 2.94372875 |
| 58 | positive regulation of histone deacetylation (GO:0031065) | 2.93531891 |
| 59 | positive regulation of interleukin-4 production (GO:0032753) | 2.91536430 |
| 60 | mannose metabolic process (GO:0006013) | 2.91430639 |
| 61 | response to peptidoglycan (GO:0032494) | 2.91343635 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 2.90959251 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 2.88166076 |
| 64 | germinal center formation (GO:0002467) | 2.85281114 |
| 65 | angiogenesis involved in wound healing (GO:0060055) | 2.84679343 |
| 66 | positive regulation of pseudopodium assembly (GO:0031274) | 2.81917463 |
| 67 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.81304799 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 2.79654891 |
| 69 | T cell costimulation (GO:0031295) | 2.79495157 |
| 70 | T cell selection (GO:0045058) | 2.78954888 |
| 71 | positive regulation of interleukin-17 production (GO:0032740) | 2.78600158 |
| 72 | regulation of interleukin-13 production (GO:0032656) | 2.77674062 |
| 73 | T cell homeostasis (GO:0043029) | 2.77614453 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76531474 |
| 75 | membrane tubulation (GO:0097320) | 2.76200895 |
| 76 | GPI anchor biosynthetic process (GO:0006506) | 2.76154920 |
| 77 | lymphocyte costimulation (GO:0031294) | 2.74888719 |
| 78 | negative regulation of phagocytosis (GO:0050765) | 2.74484453 |
| 79 | regulation of B cell apoptotic process (GO:0002902) | 2.74382355 |
| 80 | positive regulation of gliogenesis (GO:0014015) | 2.73883734 |
| 81 | response to laminar fluid shear stress (GO:0034616) | 2.73839270 |
| 82 | oligodendrocyte differentiation (GO:0048709) | 2.73209348 |
| 83 | leukocyte degranulation (GO:0043299) | 2.72795073 |
| 84 | membrane protein ectodomain proteolysis (GO:0006509) | 2.71702075 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71379109 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.71247704 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.69569731 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68633636 |
| 89 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.68592966 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 2.67549558 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.66401877 |
| 92 | protein localization to endosome (GO:0036010) | 2.66211204 |
| 93 | positive regulation of tolerance induction (GO:0002645) | 2.65754026 |
| 94 | positive T cell selection (GO:0043368) | 2.65273288 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65051263 |
| 96 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.64919961 |
| 97 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.64623447 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 2.63762387 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.63041932 |
| 100 | adhesion of symbiont to host cell (GO:0044650) | 2.62893697 |
| 101 | virion attachment to host cell (GO:0019062) | 2.62893697 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62700023 |
| 103 | cortical actin cytoskeleton organization (GO:0030866) | 2.60680906 |
| 104 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.59586159 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59463042 |
| 106 | regulation of collateral sprouting (GO:0048670) | 2.58112104 |
| 107 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.57129023 |
| 108 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.57129023 |
| 109 | tolerance induction (GO:0002507) | 2.56640611 |
| 110 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55814249 |
| 111 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55814249 |
| 112 | positive regulation of interferon-alpha production (GO:0032727) | 2.55433619 |
| 113 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.54135730 |
| 114 | positive regulation of T cell cytokine production (GO:0002726) | 2.53460187 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.52141000 |
| 116 | regulation of interferon-alpha production (GO:0032647) | 2.51907407 |
| 117 | positive regulation of glial cell differentiation (GO:0045687) | 2.51720034 |
| 118 | B cell receptor signaling pathway (GO:0050853) | 2.51670849 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.51408802 |
| 120 | leukocyte homeostasis (GO:0001776) | 2.50331535 |
| 121 | mitotic nuclear envelope reassembly (GO:0007084) | 2.50032471 |
| 122 | nuclear envelope reassembly (GO:0031468) | 2.50032471 |
| 123 | endothelium development (GO:0003158) | 2.49612226 |
| 124 | isoprenoid biosynthetic process (GO:0008299) | 2.48761200 |
| 125 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.48110356 |
| 126 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.47141925 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.45588543 |
| 128 | desmosome organization (GO:0002934) | 2.44822377 |
| 129 | leukocyte cell-cell adhesion (GO:0007159) | 2.44532915 |
| 130 | low-density lipoprotein particle clearance (GO:0034383) | 2.44027213 |
| 131 | respiratory burst (GO:0045730) | 2.43790709 |
| 132 | positive regulation of protein deacetylation (GO:0090312) | 2.43738137 |
| 133 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.43500669 |
| 134 | heterotypic cell-cell adhesion (GO:0034113) | 2.43468421 |
| 135 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.43090674 |
| 136 | negative regulation of interleukin-6 production (GO:0032715) | 2.42452847 |
| 137 | regulation of pseudopodium assembly (GO:0031272) | 2.42376359 |
| 138 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.42224251 |
| 139 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.42187362 |
| 140 | viral transcription (GO:0019083) | 2.41650294 |
| 141 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.41487310 |
| 142 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.40926306 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.39263943 |
| 144 | regulation of tolerance induction (GO:0002643) | 2.38972531 |
| 145 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.38483933 |
| 146 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.37974868 |
| 147 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35337388 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.34868678 |
| 149 | cellular extravasation (GO:0045123) | 2.34642953 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.34610390 |
| 151 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.34436099 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32583436 |
| 153 | response to host (GO:0075136) | 2.32583436 |
| 154 | response to host defenses (GO:0052200) | 2.32583436 |
| 155 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.31679780 |
| 156 | defense response to protozoan (GO:0042832) | 2.31528655 |
| 157 | response to protozoan (GO:0001562) | 2.31449038 |
| 158 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.30839114 |
| 159 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.30535188 |
| 160 | negative regulation of viral release from host cell (GO:1902187) | 2.29975153 |
| 161 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29927973 |
| 162 | response to muramyl dipeptide (GO:0032495) | 2.26754246 |
| 163 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.25171218 |
| 164 | neutrophil activation (GO:0042119) | 2.24663541 |
| 165 | regulation of leukocyte degranulation (GO:0043300) | 2.24240289 |
| 166 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.23919806 |
| 167 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23885053 |
| 168 | response to host immune response (GO:0052572) | 2.23885053 |
| 169 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.23572523 |
| 170 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.22714368 |
| 171 | regulation of B cell differentiation (GO:0045577) | 2.22673962 |
| 172 | positive regulation of isotype switching (GO:0045830) | 2.21305796 |
| 173 | negative regulation of interleukin-8 production (GO:0032717) | 2.21136019 |
| 174 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.20918723 |
| 175 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.19913619 |
| 176 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.19913619 |
| 177 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.19784947 |
| 178 | granulocyte activation (GO:0036230) | 2.17400401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.06781574 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.38668567 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94199534 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91360015 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88335119 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84258974 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81788206 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79624261 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75421656 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69813521 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50365221 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48750081 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.40825808 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.37896272 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.36019819 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.34544585 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29694296 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24886436 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12833384 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.11572571 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11193462 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05497376 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05382431 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05110221 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03932431 |
| 26 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.03816011 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.02476839 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00839805 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99517506 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 1.97974227 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97743285 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95622920 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91850219 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88178615 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78186164 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77449864 |
| 37 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77055394 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.74477875 |
| 39 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71995615 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70402848 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67074764 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63212583 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58899010 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58384508 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58071824 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55691050 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52449738 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51408220 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50824990 |
| 50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49102887 |
| 51 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47469956 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.42145277 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41819102 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39688348 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39154424 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37436076 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35588420 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31956972 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31823319 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30610807 |
| 61 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.30127719 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29532673 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29307665 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29186539 |
| 65 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28799748 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28533722 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28066559 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26569799 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26381991 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26352656 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25537832 |
| 72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.23162824 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22041394 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20647325 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19424443 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19106069 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17677054 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16904846 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16688934 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15951710 |
| 81 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.14510368 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12293164 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12260729 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11628328 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09378906 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08863013 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08826113 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08523443 |
| 89 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08470513 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08409992 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07767271 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06784036 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06468710 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06060399 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05628517 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05042033 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05024659 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04875526 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02409494 |
| 100 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02225005 |
| 101 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02053843 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01911106 |
| 103 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00956357 |
| 104 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00956357 |
| 105 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00912007 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00870896 |
| 107 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99920040 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99419085 |
| 109 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99006551 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97543992 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96113165 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95260217 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94504422 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94401664 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93707104 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93676271 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93519298 |
| 118 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93068622 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92444716 |
| 120 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91965133 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90817510 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88702162 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88004523 |
| 124 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87642921 |
| 125 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85706539 |
| 126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84923706 |
| 127 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84313749 |
| 128 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84024409 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.83124676 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83017309 |
| 131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81646587 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.79695663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.72195060 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.23215457 |
| 3 | MP0000685_abnormal_immune_system | 3.08567167 |
| 4 | MP0005671_abnormal_response_to | 2.87862092 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.77802902 |
| 6 | MP0006082_CNS_inflammation | 2.70057518 |
| 7 | MP0003950_abnormal_plasma_membrane | 2.67708800 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.43383317 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.40479433 |
| 10 | MP0001790_abnormal_immune_system | 2.36803094 |
| 11 | MP0005387_immune_system_phenotype | 2.36803094 |
| 12 | MP0001800_abnormal_humoral_immune | 2.31776715 |
| 13 | MP0002723_abnormal_immune_serum | 2.31771626 |
| 14 | MP0009785_altered_susceptibility_to | 2.31311428 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.29722917 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.26307317 |
| 17 | MP0005025_abnormal_response_to | 2.24927517 |
| 18 | MP0001819_abnormal_immune_cell | 2.23841291 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.19237248 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.15693602 |
| 21 | MP0009840_abnormal_foam_cell | 2.10876305 |
| 22 | MP0002398_abnormal_bone_marrow | 2.07599812 |
| 23 | MP0004381_abnormal_hair_follicle | 2.03792343 |
| 24 | MP0002419_abnormal_innate_immunity | 2.03249271 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.02475463 |
| 26 | MP0000716_abnormal_immune_system | 1.98637713 |
| 27 | MP0002254_reproductive_system_inflammat | 1.98035016 |
| 28 | MP0003724_increased_susceptibility_to | 1.96878293 |
| 29 | MP0003436_decreased_susceptibility_to | 1.95055074 |
| 30 | MP0002405_respiratory_system_inflammati | 1.94420609 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.91410873 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.90437662 |
| 33 | MP0002933_joint_inflammation | 1.89353019 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.87672398 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.78027780 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.75991461 |
| 37 | MP0002722_abnormal_immune_system | 1.73568544 |
| 38 | MP0005451_abnormal_body_composition | 1.71138708 |
| 39 | MP0001851_eye_inflammation | 1.68536965 |
| 40 | MP0002429_abnormal_blood_cell | 1.67185384 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.63168824 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.60606398 |
| 43 | MP0004947_skin_inflammation | 1.57088243 |
| 44 | MP0003690_abnormal_glial_cell | 1.56274651 |
| 45 | MP0003279_aneurysm | 1.55191986 |
| 46 | MP0002796_impaired_skin_barrier | 1.55054931 |
| 47 | MP0009278_abnormal_bone_marrow | 1.50937475 |
| 48 | MP0003866_abnormal_defecation | 1.47156059 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.45191687 |
| 50 | MP0001873_stomach_inflammation | 1.40676870 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.40025154 |
| 52 | MP0003828_pulmonary_edema | 1.38304215 |
| 53 | MP0002060_abnormal_skin_morphology | 1.35572951 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.34780058 |
| 55 | MP0000383_abnormal_hair_follicle | 1.33465998 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.33163445 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.31242850 |
| 58 | MP0003303_peritoneal_inflammation | 1.29426751 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.28706787 |
| 60 | MP0005501_abnormal_skin_physiology | 1.28393763 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.26397261 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.26144436 |
| 63 | MP0000490_abnormal_crypts_of | 1.24066573 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.21927891 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.21927891 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.21764691 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.20887822 |
| 68 | MP0004510_myositis | 1.18680024 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.18501732 |
| 70 | MP0001216_abnormal_epidermal_layer | 1.15529180 |
| 71 | MP0003448_altered_tumor_morphology | 1.14213594 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.12078074 |
| 73 | MP0002132_abnormal_respiratory_system | 1.11499791 |
| 74 | MP0005410_abnormal_fertilization | 1.11478876 |
| 75 | MP0005023_abnormal_wound_healing | 1.10720212 |
| 76 | MP0001853_heart_inflammation | 1.09142505 |
| 77 | MP0008057_abnormal_DNA_replication | 1.09009861 |
| 78 | MP0009764_decreased_sensitivity_to | 1.08978888 |
| 79 | MP0008004_abnormal_stomach_pH | 1.08656216 |
| 80 | MP0003045_fibrosis | 1.05302919 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 1.05151173 |
| 82 | MP0008260_abnormal_autophagy | 1.03554836 |
| 83 | MP0005310_abnormal_salivary_gland | 0.99415234 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.98448903 |
| 85 | MP0003634_abnormal_glial_cell | 0.97823970 |
| 86 | MP0009931_abnormal_skin_appearance | 0.97734729 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.96967454 |
| 88 | MP0003075_altered_response_to | 0.96795737 |
| 89 | MP0005164_abnormal_response_to | 0.96221200 |
| 90 | MP0003091_abnormal_cell_migration | 0.95710651 |
| 91 | MP0003136_yellow_coat_color | 0.94452174 |
| 92 | MP0005166_decreased_susceptibility_to | 0.93467477 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.91725501 |
| 94 | MP0004883_abnormal_blood_vessel | 0.89596247 |
| 95 | MP0004134_abnormal_chest_morphology | 0.89453068 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.88738151 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.87479064 |
| 98 | MP0000733_abnormal_muscle_development | 0.86793247 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.84855152 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.84670635 |
| 101 | MP0008469_abnormal_protein_level | 0.84669788 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.84234190 |
| 103 | MP0006054_spinal_hemorrhage | 0.84064253 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.82148103 |
| 105 | MP0000249_abnormal_blood_vessel | 0.81323290 |
| 106 | MP0003329_amyloid_beta_deposits | 0.81149424 |
| 107 | MP0004742_abnormal_vestibular_system | 0.80253126 |
| 108 | MP0005409_darkened_coat_color | 0.79863538 |
| 109 | MP0001958_emphysema | 0.79485694 |
| 110 | MP0000858_altered_metastatic_potential | 0.79365794 |
| 111 | MP0004272_abnormal_basement_membrane | 0.78352992 |
| 112 | MP0000604_amyloidosis | 0.78027257 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.77212163 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.77193054 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.73822394 |
| 116 | MP0003077_abnormal_cell_cycle | 0.73467772 |
| 117 | MP0001243_abnormal_dermal_layer | 0.71191556 |
| 118 | MP0008873_increased_physiological_sensi | 0.70456649 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.70417855 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.70408140 |
| 121 | MP0005171_absent_coat_pigmentation | 0.69869214 |
| 122 | MP0004142_abnormal_muscle_tone | 0.68460610 |
| 123 | MP0009763_increased_sensitivity_to | 0.67867185 |
| 124 | MP0001849_ear_inflammation | 0.67520155 |
| 125 | MP0000377_abnormal_hair_follicle | 0.66191781 |
| 126 | MP0002006_tumorigenesis | 0.65359450 |
| 127 | MP0000343_altered_response_to | 0.65354910 |
| 128 | MP0005390_skeleton_phenotype | 0.64220437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.08764730 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53358810 |
| 3 | T lymphocytopenia (HP:0005403) | 4.15947934 |
| 4 | Cerebral hypomyelination (HP:0006808) | 3.99069916 |
| 5 | Abnormality of T cell number (HP:0011839) | 3.96743253 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.92293913 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.92293913 |
| 8 | Stomatitis (HP:0010280) | 3.85945391 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.70370772 |
| 10 | Orchitis (HP:0100796) | 3.58907800 |
| 11 | Peripheral hypomyelination (HP:0007182) | 3.57139447 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.40173650 |
| 13 | Parakeratosis (HP:0001036) | 3.38749945 |
| 14 | Hepatosplenomegaly (HP:0001433) | 3.31724822 |
| 15 | Sensory axonal neuropathy (HP:0003390) | 3.28910954 |
| 16 | Increased IgE level (HP:0003212) | 3.20754404 |
| 17 | IgM deficiency (HP:0002850) | 3.16368880 |
| 18 | Premature skin wrinkling (HP:0100678) | 3.14803914 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 3.10470908 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.10089006 |
| 21 | Optic neuritis (HP:0100653) | 3.08821810 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.08821810 |
| 23 | Nasal polyposis (HP:0100582) | 3.06698987 |
| 24 | Recurrent bronchitis (HP:0002837) | 2.97560745 |
| 25 | Onion bulb formation (HP:0003383) | 2.92989985 |
| 26 | Abnormality of T cells (HP:0002843) | 2.91383017 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 2.90641218 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.88594001 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.87535605 |
| 30 | Recurrent viral infections (HP:0004429) | 2.86156065 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.83500657 |
| 32 | Combined immunodeficiency (HP:0005387) | 2.83011492 |
| 33 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.80599208 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.77715600 |
| 35 | Stridor (HP:0010307) | 2.77592759 |
| 36 | Petechiae (HP:0000967) | 2.76565553 |
| 37 | Recurrent skin infections (HP:0001581) | 2.75320602 |
| 38 | Fragile skin (HP:0001030) | 2.73543665 |
| 39 | Purpura (HP:0000979) | 2.72712201 |
| 40 | Myositis (HP:0100614) | 2.72123047 |
| 41 | Premature loss of primary teeth (HP:0006323) | 2.71767396 |
| 42 | Leukocytosis (HP:0001974) | 2.71215305 |
| 43 | Abnormality of eosinophils (HP:0001879) | 2.68644623 |
| 44 | Peritonitis (HP:0002586) | 2.63764332 |
| 45 | Cellulitis (HP:0100658) | 2.63753040 |
| 46 | Pustule (HP:0200039) | 2.62516631 |
| 47 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.61544136 |
| 48 | Loss of speech (HP:0002371) | 2.60676105 |
| 49 | Abnormal auditory evoked potentials (HP:0006958) | 2.56372511 |
| 50 | Plantar hyperkeratosis (HP:0007556) | 2.54222116 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.53340897 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.52036847 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.50668894 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.49962574 |
| 55 | IgG deficiency (HP:0004315) | 2.49791822 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.49161127 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47860985 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47860985 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47860985 |
| 60 | Eosinophilia (HP:0001880) | 2.46020576 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45706832 |
| 62 | Asplenia (HP:0001746) | 2.44112732 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40888060 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40888060 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40888060 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.35881169 |
| 67 | Milia (HP:0001056) | 2.33117385 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.31359205 |
| 69 | Hemoptysis (HP:0002105) | 2.31239414 |
| 70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31013687 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31013687 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.30572796 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30572796 |
| 74 | CNS hypomyelination (HP:0003429) | 2.30297326 |
| 75 | Obstructive lung disease (HP:0006536) | 2.29470219 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29470219 |
| 77 | Urticaria (HP:0001025) | 2.28819917 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.28546911 |
| 79 | Atrophic scars (HP:0001075) | 2.28235095 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.26390800 |
| 81 | Cerebral aneurysm (HP:0004944) | 2.25541288 |
| 82 | Verrucae (HP:0200043) | 2.23957927 |
| 83 | Papilloma (HP:0012740) | 2.23957927 |
| 84 | Lymphopenia (HP:0001888) | 2.22832690 |
| 85 | Abnormality of the corticospinal tract (HP:0002492) | 2.21854723 |
| 86 | Granulocytopenia (HP:0001913) | 2.21550970 |
| 87 | Vasculitis (HP:0002633) | 2.21311340 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 2.20929656 |
| 89 | Thyroiditis (HP:0100646) | 2.20818328 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.20372039 |
| 91 | Spastic paraparesis (HP:0002313) | 2.20176354 |
| 92 | Axonal loss (HP:0003447) | 2.19978456 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.18973011 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.18690832 |
| 95 | Thick nail (HP:0001805) | 2.17816504 |
| 96 | Abnormal platelet volume (HP:0011876) | 2.16947145 |
| 97 | White forelock (HP:0002211) | 2.15562662 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15423848 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.15350475 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.15259692 |
| 101 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.14670270 |
| 102 | Premature rupture of membranes (HP:0001788) | 2.13906233 |
| 103 | Chest pain (HP:0100749) | 2.10799532 |
| 104 | Gingivitis (HP:0000230) | 2.08055612 |
| 105 | Patchy hypopigmentation of hair (HP:0011365) | 2.06719328 |
| 106 | Fragile nails (HP:0001808) | 2.06584445 |
| 107 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06113226 |
| 108 | Abnormal blistering of the skin (HP:0008066) | 2.04972078 |
| 109 | Aplasia cutis congenita (HP:0001057) | 2.04773328 |
| 110 | Prolonged neonatal jaundice (HP:0006579) | 2.03320936 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 2.03055517 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 2.02919836 |
| 113 | Spondylolisthesis (HP:0003302) | 2.02900037 |
| 114 | Chronic diarrhea (HP:0002028) | 2.01824689 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 2.00467246 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.99739745 |
| 117 | Agammaglobulinemia (HP:0004432) | 1.98730243 |
| 118 | Osteomyelitis (HP:0002754) | 1.98705504 |
| 119 | Muscle fibrillation (HP:0010546) | 1.98606434 |
| 120 | Meningitis (HP:0001287) | 1.97725250 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.96503351 |
| 122 | Episodic fever (HP:0001954) | 1.93931485 |
| 123 | Colitis (HP:0002583) | 1.93192996 |
| 124 | Hypertensive crisis (HP:0100735) | 1.93073745 |
| 125 | Nail dystrophy (HP:0008404) | 1.92800950 |
| 126 | Alopecia of scalp (HP:0002293) | 1.91647179 |
| 127 | Skin ulcer (HP:0200042) | 1.91629473 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.88951349 |
| 129 | Ulnar bowing (HP:0003031) | 1.88771623 |
| 130 | Partial duplication of thumb phalanx (HP:0009944) | 1.87731660 |
| 131 | Increased IgM level (HP:0003496) | 1.87525080 |
| 132 | Esophageal atresia (HP:0002032) | 1.87488524 |
| 133 | B lymphocytopenia (HP:0010976) | 1.87472175 |
| 134 | Abnormality of B cell number (HP:0010975) | 1.87472175 |
| 135 | Encephalitis (HP:0002383) | 1.86735249 |
| 136 | Palmoplantar hyperkeratosis (HP:0000972) | 1.86513947 |
| 137 | Fatigue (HP:0012378) | 1.86103652 |
| 138 | Epistaxis (HP:0000421) | 1.85818868 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.85623988 |
| 140 | Lymphoma (HP:0002665) | 1.85220695 |
| 141 | Increased serum ferritin (HP:0003281) | 1.84942207 |
| 142 | Joint stiffness (HP:0001387) | 1.84689468 |
| 143 | Morphological abnormality of the inner ear (HP:0011390) | 1.84595331 |
| 144 | Sepsis (HP:0100806) | 1.84510461 |
| 145 | Thrombocytosis (HP:0001894) | 1.83942923 |
| 146 | Cheilitis (HP:0100825) | 1.83829821 |
| 147 | Seborrheic dermatitis (HP:0001051) | 1.83429167 |
| 148 | Hematochezia (HP:0002573) | 1.82800493 |
| 149 | Arterial thrombosis (HP:0004420) | 1.82771557 |
| 150 | Prolonged bleeding time (HP:0003010) | 1.82266182 |
| 151 | Hypertriglyceridemia (HP:0002155) | 1.82071360 |
| 152 | Malnutrition (HP:0004395) | 1.80754417 |
| 153 | Paraparesis (HP:0002385) | 1.80153268 |
| 154 | Distal lower limb muscle weakness (HP:0009053) | 1.79244256 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.79038205 |
| 156 | Osteolytic defects of the hand bones (HP:0009699) | 1.78928365 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.78928365 |
| 158 | Increased connective tissue (HP:0009025) | 1.78777229 |
| 159 | Inflammation of the large intestine (HP:0002037) | 1.78304103 |
| 160 | Gingival bleeding (HP:0000225) | 1.77766270 |
| 161 | Abnormality of the peritoneum (HP:0002585) | 1.77554236 |
| 162 | Thin bony cortex (HP:0002753) | 1.76874818 |
| 163 | Cervical subluxation (HP:0003308) | 1.75958484 |
| 164 | Erythroderma (HP:0001019) | 1.75827673 |
| 165 | J-shaped sella turcica (HP:0002680) | 1.75370368 |
| 166 | Emphysema (HP:0002097) | 1.75278839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 4.30092389 |
| 2 | MAP4K1 | 4.12632668 |
| 3 | ERN1 | 3.73496498 |
| 4 | STK39 | 3.26518395 |
| 5 | TESK2 | 3.21323879 |
| 6 | IRAK3 | 2.86359157 |
| 7 | STK10 | 2.52752127 |
| 8 | SIK1 | 2.49793053 |
| 9 | TXK | 2.49234315 |
| 10 | EPHA2 | 2.47790703 |
| 11 | MST1R | 2.45567679 |
| 12 | CLK1 | 2.38854775 |
| 13 | MAP3K3 | 2.36245411 |
| 14 | SMG1 | 2.31144176 |
| 15 | MST4 | 2.28275860 |
| 16 | EEF2K | 2.25282771 |
| 17 | TRIB3 | 2.18564936 |
| 18 | MAP2K3 | 2.03234019 |
| 19 | NME2 | 2.02169137 |
| 20 | BLK | 1.93865918 |
| 21 | JAK3 | 1.80511444 |
| 22 | ZAP70 | 1.79119682 |
| 23 | OXSR1 | 1.78678871 |
| 24 | MAPKAPK5 | 1.77553389 |
| 25 | TAOK2 | 1.77109494 |
| 26 | PKN1 | 1.67218023 |
| 27 | SIK3 | 1.63980563 |
| 28 | ITK | 1.63226996 |
| 29 | NLK | 1.61149201 |
| 30 | CDK19 | 1.56517008 |
| 31 | RIPK4 | 1.55613925 |
| 32 | BTK | 1.50599531 |
| 33 | TBK1 | 1.50512511 |
| 34 | KDR | 1.46008467 |
| 35 | TNK2 | 1.45895057 |
| 36 | IKBKE | 1.40686105 |
| 37 | LCK | 1.36433539 |
| 38 | IRAK4 | 1.33944315 |
| 39 | LIMK1 | 1.28754621 |
| 40 | LRRK2 | 1.28237537 |
| 41 | MAP2K6 | 1.27179801 |
| 42 | MET | 1.26171145 |
| 43 | KIT | 1.23464119 |
| 44 | PTK6 | 1.21023094 |
| 45 | MAP3K1 | 1.20038999 |
| 46 | PBK | 1.18927218 |
| 47 | BUB1 | 1.18121744 |
| 48 | TGFBR2 | 1.17606078 |
| 49 | ICK | 1.16163213 |
| 50 | IKBKB | 1.15256076 |
| 51 | CSK | 1.14349106 |
| 52 | TYK2 | 1.11646416 |
| 53 | MAP3K10 | 1.10019277 |
| 54 | MAPKAPK3 | 1.10010830 |
| 55 | TAOK1 | 1.09952341 |
| 56 | GRK6 | 1.09671061 |
| 57 | MAP3K14 | 1.07974619 |
| 58 | CSF1R | 1.07965223 |
| 59 | CSNK1G3 | 1.07953956 |
| 60 | RIPK1 | 1.05600503 |
| 61 | PKN2 | 1.00228663 |
| 62 | TRPM7 | 0.98486078 |
| 63 | RPS6KA5 | 0.98210096 |
| 64 | LMTK2 | 0.97459823 |
| 65 | CSNK1A1L | 0.96980072 |
| 66 | FER | 0.93426474 |
| 67 | TAOK3 | 0.92121444 |
| 68 | TIE1 | 0.91999800 |
| 69 | CSNK1G1 | 0.88735641 |
| 70 | ROCK2 | 0.87971178 |
| 71 | MAP3K13 | 0.86653031 |
| 72 | TEC | 0.86293008 |
| 73 | FGR | 0.84016723 |
| 74 | HCK | 0.83421944 |
| 75 | PRKCQ | 0.83195604 |
| 76 | PIM2 | 0.82784305 |
| 77 | MAP2K2 | 0.82047346 |
| 78 | PRKD2 | 0.81984941 |
| 79 | IRAK1 | 0.81166331 |
| 80 | FGFR2 | 0.80610932 |
| 81 | FGFR4 | 0.79951324 |
| 82 | MAP3K8 | 0.78553153 |
| 83 | TESK1 | 0.76512376 |
| 84 | MAP3K7 | 0.74613808 |
| 85 | PIM1 | 0.74581170 |
| 86 | RPS6KA4 | 0.71956694 |
| 87 | SYK | 0.70462939 |
| 88 | MARK2 | 0.68696943 |
| 89 | STK4 | 0.67436201 |
| 90 | TYRO3 | 0.66630067 |
| 91 | MAP3K11 | 0.66004975 |
| 92 | EPHB2 | 0.65854635 |
| 93 | CDC42BPA | 0.65153134 |
| 94 | BMX | 0.64884155 |
| 95 | PRKG2 | 0.64752940 |
| 96 | PTK2B | 0.63699840 |
| 97 | MAPK11 | 0.62430223 |
| 98 | PAK1 | 0.60607551 |
| 99 | PTK2 | 0.59899461 |
| 100 | UHMK1 | 0.59593482 |
| 101 | MAPKAPK2 | 0.59365829 |
| 102 | WNK4 | 0.58579766 |
| 103 | MARK3 | 0.57978991 |
| 104 | LYN | 0.57246349 |
| 105 | PRKD1 | 0.56335936 |
| 106 | PRKCI | 0.56127576 |
| 107 | FES | 0.55328256 |
| 108 | BCR | 0.52217509 |
| 109 | JAK1 | 0.51368016 |
| 110 | STK38 | 0.51230654 |
| 111 | MOS | 0.50707753 |
| 112 | TNIK | 0.49925969 |
| 113 | HIPK2 | 0.49918170 |
| 114 | MAP3K2 | 0.49804711 |
| 115 | CDK4 | 0.48371741 |
| 116 | MAPK12 | 0.48178450 |
| 117 | TLK1 | 0.47814234 |
| 118 | MAPK7 | 0.47344025 |
| 119 | DYRK3 | 0.47296614 |
| 120 | PAK4 | 0.47008803 |
| 121 | FGFR3 | 0.46523110 |
| 122 | PRKCH | 0.46426310 |
| 123 | MATK | 0.46062782 |
| 124 | IRAK2 | 0.45479545 |
| 125 | CAMK2B | 0.44988076 |
| 126 | NEK2 | 0.44455049 |
| 127 | JAK2 | 0.44113168 |
| 128 | STK24 | 0.43069588 |
| 129 | RPS6KL1 | 0.42590089 |
| 130 | RPS6KC1 | 0.42590089 |
| 131 | RPS6KA2 | 0.42041685 |
| 132 | PDGFRB | 0.40884442 |
| 133 | GSK3A | 0.39751898 |
| 134 | PDK1 | 0.38914571 |
| 135 | INSR | 0.38061897 |
| 136 | WNK1 | 0.35504690 |
| 137 | CSNK1G2 | 0.34946841 |
| 138 | PRPF4B | 0.34101876 |
| 139 | CHUK | 0.33950002 |
| 140 | FYN | 0.33864409 |
| 141 | PDPK1 | 0.32430010 |
| 142 | RPS6KB2 | 0.32379102 |
| 143 | PAK2 | 0.31706989 |
| 144 | MELK | 0.31342080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.59645490 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.37423283 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.21612854 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.79302200 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.50495397 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.30842754 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.18070184 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97515084 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92246464 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85355455 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79922696 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.74046835 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.72735068 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68867958 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64691156 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60906262 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56309779 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.56010039 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56005575 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53460058 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47115769 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.43347114 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42186820 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41603697 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40225867 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.39878847 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36422592 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36237200 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35761175 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34889516 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.33372511 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.32949643 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29821625 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27545019 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18863798 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18693002 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14848722 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10084696 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09017221 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06058307 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02211885 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.01925879 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01505721 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01333179 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00838582 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00193273 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99508208 |
| 48 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98046881 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.97367455 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95880307 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.94661006 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94173886 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.91348894 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90887045 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90314118 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89576949 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89358155 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88406398 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.87860946 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87438848 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87050633 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.86970525 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86774010 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86717070 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.85677834 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84882793 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83667930 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.83193901 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83160036 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83135327 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82807472 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82494556 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81033687 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79331358 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79181841 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79050502 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.78056555 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77570176 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.76851166 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.76214232 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.75958432 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.75514989 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75307128 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.74695139 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.74636193 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.74535845 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.74482060 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74374487 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73114088 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72022584 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71480996 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70666652 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70509161 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.69374940 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.69128155 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68535131 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68399226 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68140216 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66187416 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65347162 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64595182 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.63050951 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62709624 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61745280 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60500007 |
| 106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58931134 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57359482 |
| 108 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57303961 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57133262 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56145855 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54520780 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53837840 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53714334 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.53293298 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52502358 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51974472 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51792233 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50679729 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.50601179 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50135815 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50022343 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49672107 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.49064394 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48839046 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48430871 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48347844 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45821245 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.45810696 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45435156 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43916321 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43269883 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42563890 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42516116 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41736378 |

